These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8184989)

  • 21. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopamine receptors in the central nervous system.
    Creese I; Sibley DR; Hamblin MW; Leff SE
    Adv Biochem Psychopharmacol; 1983; 36():125-34. PubMed ID: 6344562
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor.
    Hwang CK; D'Souza UM; Eisch AJ; Yajima S; Lammers CH; Yang Y; Lee SH; Kim YM; Nestler EJ; Mouradian MM
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7558-63. PubMed ID: 11390978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for, and localization of, a unitary dopamine receptor composed of cooperatively linked subunit binding sites in rat striatum.
    Leysen JE; Gommeren W; Laduron PM
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):312-4. PubMed ID: 543764
    [No Abstract]   [Full Text] [Related]  

  • 26. Intraventricular injection of neurotensin reduces the binding of dopamine D-2 receptors in the rat forebrain.
    von Euler G; Meister B; Hökfelt T; Fuxe K
    Acta Physiol Scand; 1989 Oct; 137(2):309-10. PubMed ID: 2618764
    [No Abstract]   [Full Text] [Related]  

  • 27. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P; Guan HC; Van Tol HH; Niznik HB
    Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine receptor binding activity of anti-parkinsonian active piperazino derivatives.
    Srivastava VK; Palit G; Agarwal AK; Shanker K
    Indian J Exp Biol; 1988 Jan; 26(1):15-7. PubMed ID: 3403004
    [No Abstract]   [Full Text] [Related]  

  • 29. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
    Rogue P; Zwiller J; Malviya AN; Vincendon G
    Biochem Int; 1990 Nov; 22(3):575-82. PubMed ID: 1981673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Brain--inside and outside].
    Friberg L
    Ugeskr Laeger; 2002 Apr; 164(17):2257. PubMed ID: 11989172
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effects of activity level on striatal binding: Careful replication is required.
    Corcos DM
    Parkinsonism Relat Disord; 2023 Oct; 115():105856. PubMed ID: 37770321
    [No Abstract]   [Full Text] [Related]  

  • 33. Human brain receptors,V. Binding and message.
    Meador-Woodruff JH; Watson SJ; Tamminga CA
    Am J Psychiatry; 1994 Jun; 151(6):804. PubMed ID: 8184989
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitation of neuroreceptors: a need to increase imaging resolution?
    Kuikka JT
    J Nucl Med; 1996 Nov; 37(11):1911-2. PubMed ID: 8917202
    [No Abstract]   [Full Text] [Related]  

  • 35. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
    Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
    J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.
    Fuxe K; Strömberg I; Popoli P; Rimondini-Giorgini R; Torvinen M; Ogren SO; Franco R; Agnati LF; Ferré S
    Adv Neurol; 2001; 86():345-53. PubMed ID: 11553995
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopamine receptors in Parkinson's disease.
    Guttman M
    Neurol Clin; 1992 May; 10(2):377-86. PubMed ID: 1584180
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.